2007 Annual Meeting | Dementia Update

Date Monday 04/30/07

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Neill R. Graff-Radford, MD, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the differential diagnosis of dementia; recognize the clinical features of the different dementias; understand the basis for amyloid being a therapeutic target in Alzheimer's disease; be aware of the advances in the genetics of frontotemporal dementia; and recognize the usefulness of mouse models in testing treatments for these diseases.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Alzheimer's Disease Ronald C. Petersen, MD, PhD, FAAN
09:45 AM - 10:30 AM		Why the Amyloid Beta Potein Is a Therapeutic Target Dennis J. Selkoe, MD, FAAN
10:30 AM - 10:45 AM		Questions and Answers
10:45 AM - 11:00 AM		Break
11:00 AM - 11:45 AM		Prion Diseases Eric R. Eggenberger, DO, FAAN
11:45 AM - 12:00 PM		Questions and Answers
12:00 PM - 01:30 PM		Break
01:30 PM - 02:15 AM		Frontotemporal Dementia Neill R. Graff-Radford, MD, FAAN
02:15 PM - 03:00 PM		Frontotemporal Dementia Genetics and Mouse Models of Degenerative Disease Michael Hutton, PhD
03:00 PM - 03:15 PM		Questions and Answers
03:15 PM - 03:30 PM		Break
03:30 PM - 04:15 PM		Vascular Dementia Helena C. Chui, MD
04:15 PM - 05:00 PM		Parkinsonian Dementias Bradley F. Boeve, MD, FAAN
05:00 PM - 05:15 PM		Questions and Answers

Faculty Disclosures
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT).
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Dennis J. Selkoe, MD, FAAN	Dr. Selkoe has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prothena Biosciences. Dr. Selkoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI.
Michael Hutton, PhD	No disclosure on file
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��